COVID-19 vaccine more than 90% effective according to pharmaceutical giant, Pfizer

by Danielle Sanders

As the world grapples with an increase in COVID-19 cases, Pharmaceutical giants, Pfizer and BioNTech announced their vaccine against the Coronavirus is more than 90% effective, based on the first interim efficacy analysis conducted on November 8, 2020, by an external, independent Data Monitoring Committee (DMC) from the Phase 3 clinical study.

“Today is a great day for science and humanity. With today’s news, we are a significant step closer to providing people around the world with a much-needed breakthrough to help bring an end to this global health crisis. We look forward to sharing additional efficacy and safety data generated from thousands of participants in the coming weeks.”-Dr. Albert Bourla, Pfizer CEO

The reported analysis evaluated 94 confirmed cases of COVID-19 in participants.  Over 43,000 participants were involved in the study with 42% of them having diverse backgrounds.  The vaccine was found to be more


Click to read the full article @New Pittsburgh Courier